MAPT and Alzheimer disease: Furthermore, studies in several distinct animal models driven by Aβ, inflammation, or tau showed that spatial learning and working memory deficits are reversed with small molecule inhibitors of p38α kinase activity [120,121,122], providing direct evidence that inhibition of p38α activity has therapeutic potential in AD.